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The aim of the current study was to evaluate microbial contamination in terms of microbial load (total aerobic count and total
coliform count) and specific pathogenic bacteria (Salmonella spp., Escherichia coli, particularly Escherichia coli 0157) in thirteen
antidiabetic herbal preparations (ADHPs) from Dhaka City. All the thirteen ADHPs had been found contaminated with fungi and
different pathogenic bacteria. From the data, it is found that only two of these preparations (ADHP-1 and ADHP-12) complied with
the safety limit (as stated in different Pharmacopoeias and WHO guidelines) evaluated by all different microbial counts. None of
these herbal preparations could assure the safety as all of them were contaminated by fungi. The overall safety regarding heavy
metal content (Zn, Cu, Mn, Cr, Cd, and Pb) was assured as none of them exceeded the safety limit of the daily intake. Microbial
contaminants in these herbal preparations pose a potential risk for human health and care should be taken in every step involved
in the preparation of these herbal preparations to assure safety.
1. Introduction
Over the recent times, the popularity of herbal medicine
is increased to such an extent that around 20% of world
population is now using herbal medicine in different forms
for different purposes [1]. In developing countries, it is
estimated that 70–80% of the population somehow relay
on nonconventional medicines mainly of herbal origins for
their primary health care [2], as they are cheap and easily
accessible [3]. Herbal preparations are produced from any
raw or processed part of a plant, which includes leaves,
stems, flowers, roots, and seeds, and in most of the cases
it is a complex mixture of organic chemicals from natural
sources [1, 4, 5]. As different plant parts are used in a herbal
preparation, it may carry a large number of various kinds of
microbes originating from soil usually adhering to different
parts of herbs [5] (Table 1). Moreover, in some of the herbal
preparations, particularly Ayurvedic formulation, the use of
heavy metals is intentional, as some of these heavy metals
are believed to have beneficial effect on our body. In general,
most common contaminants are heavy metals, pesticides,
microbes, and mycotoxins [6, 7].
The range of the usage [8] of herbal preparations is
vast as they are frequently used in the treatment of several
chronic diseases including type 2 diabetes (diabetesmellitus).
Diabetes is a noncommunicable heterogeneous group of
disorder and affects approximately 200 million individuals
globally.Moreover, it is predicted that over 300million people
will be diabetic by 2015 [8, 9]. In general, this poses challenges
to the health care and social welfare but, in particular, it is
a huge challenge to a developing country like Bangladesh
because of its limited resources and weak economy. The
trend of uses of antidiabetic herbal preparations (mostly
based on Ayurvedic and Unani formulary) is increasing day
by day among the population of Bangladesh. In parallel,
there is a rising concern regarding the safety and efficacy
of these herbal preparations as most of them contain dif-
ferent contaminants including microbial contaminants and
heavy metals (particularly in Ayurvedic preparation). In
most of the developed countries, herbal preparations are
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Table 1: Composition of different antidiabetic herbal preparations (ADHPs) and daily adult dose as indicated on the label of the products.
Sample ID Brand name Composition of the preparation as indicatedon the label of finished product Daily adult (70 kg bw) dose in g pH
ADHP-1 Diacare






Natrum sulfuricum (a constitutional
homeopathy remedy)























Myristica fragrans (dried kernel of the seed)
Syzygium aromaticum (flower)
3.75 8.18






Myristica fragrans (dried kernel of the seed)
Syzygium aromaticum (flower)
3.5 7.83
ADHP-9 Methicrash Trigonella foenum-graecum (seed) 30 6.70
ADHP-10 Diano








ADHP-11 Azardiracha Indica Azadirachta indica (leaf extract) 2.5 6.35
ADHP-12 Cuzium Jam Cinnamomum zeylanicum (bark)Accacia acuminate (seeds) 4 5.72
ADHP-13 Silaraj





defined as dietary supplement. As a result, unlike pharma-
ceutical preparations, manufacturers are producing, selling,
and marketing herbal preparations without any evidence
based scientific study regarding their safety and efficacy [1].
Although in several countries herbal medicine (a part of
complementary and alternative medicine) is the officially
approved system, there is no guidelines and regulations for
assuring the safety of these preparations. The safety of these
herbal preparations is very important because Ayurvedic
formulation contains several heavy metals as therapeutic
ingredients. But the use of these heavy metals beyond
the limit could be toxic. Moreover, the level of microbial
contamination of herbal preparations is dependent on the
quality of the rawmaterials used and themanufacturing envi-
ronment. Most rawmaterials for herbal preparations support
some form of microbial growth, as medicinal plants used
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in herbal preparations provide nutrition to microorganisms
and facilitate the multiplication of microorganism. In addi-
tion, inappropriate cleaning, unsuitable transportation, pro-
longed drying and storage, inadequate hygiene of produc-
ers, and congenital climatic conditions render the medici-
nal plants vulnerable to infestations and exposed them to
many microbial contaminants. Inadvertent contamination,
like fungal contamination during the production stage can
also lead to deterioration in safety and quality as the risk
of mycotoxin production, especially aflatoxin, may arise
which has proven mutagenic, carcinogenic, teratogenic, neu-
rotoxic, nephrotoxic, and immunosuppressive activities [10–
16]. Therefore, it is important to evaluate the safety of these
antidiabetic herbal preparations based on relevant scientific
investigation. This research project focused on the safety
of antidiabetic herbal preparations available in Bangladesh
particularly related to heavy metal and microbial contami-
nation.
In Bangladesh, several antidiabetic herbal preparations
are readily available and are being used, but studies regarding
microbial contaminants and heavy metal content in locally
produced herbal preparations are limited. Therefore, it is
necessary to evaluate microbial contamination as well as
heavy metal content in some locally produced and widely
used herbal preparations. In this study, we investigated the
level of microbial contamination and heavy metal content
present in antidiabetic herbal preparations widely used and
formulated in Bangladesh.
2. Materials and Methods
2.1. Study Area and Sample Collection. Samples of thirteen
antidiabetic herbal preparations (ADHPs) as finished com-
mercial pack were purchased randomly from different herbal
medicine outlets of Dhaka City. Initially, all the samples were
prepared for analysis in the research laboratory, Daffodil
International University (DIU), Dhaka, Bangladesh. Micro-
biological contamination and heavy metal content were
analyzed in the Center for Advanced Research in Sciences
(CARS), University of Dhaka, Bangladesh.
2.2. Determination of pH. The pH of different herbal prepa-
rations was determined by using microprocessor pH meter
(HI 2210; Hanna Instrument, USA) as described earlier
[17]. For pH determination, sample solution was prepared
by dissolving 12.5 g in 100mL sterile distilled water with
shaking to obtain a homogenous solution. The pH of the
solution of different herbal preparations was measured by
microprocessor pH meter and the data are presented as the
average of triplicate.
2.3. Preparation of Media. All the media for microbiolog-
ical analysis were prepared according to the manufacture’s
guidelines and sterilized in an autoclave (CL-32S; ALP Co.
Ltd., Japan) at 121∘C for 40 minutes. The sterile media were
dispensed or poured into sterilized Petri dishes or test tube as
required. The sterility of the prepared media was confirmed
by incubating blindly selected plates at 37∘C for overnight.
2.4. Total Aerobic Bacterial Count and Total Coliform Count.
Total aerobic bacterial count was performed to assess the
quality and shelf life of the herbal formulation. Twenty-five
(25) g of each sample was homogenized in 225mL of sterile
saline water. After that, 0.1mL from twofold diluted samples
was spread on a Petri dish containing Tryptic Soy Agar (TSA)
(Oxoid Ltd., Hampshire, England) and incubated at 35∘C
for 24 hours for total aerobic bacterial count [18]. To assess
the hygiene of the formulations, total coliform count was
performed by spreading 0.1mLof the sample (as used for total
aerobic count) on MacConkey agar (Oxoid Ltd., Hampshire,
England) and was incubated at 35∘C and 42∘C for 24 hours
[19].
2.5. Escherichia coli 0157. Twenty-five (25) g of each sample
was homogenized in 225mL EC medium and incubated at
42∘C for 20 hours. The enriched cultures were streaked onto
Sorbitol MacConkey agar complemented with Cefixime and
potassium tellurite supplement and characteristic colonies
were subjected to biochemical tests (IMViC). Biochemically
confirmed isolates were screened through caprylate-thallous
agar (CTA) and CHROMagar. The colonies, which gave
characteristic color, were subsequently serotyped by 0157
antisera.
2.6. Escherichia coli (Total). Twenty-five (25) g of each sam-
ple was homogenized in 225mL Enterobacteria enrichment
broth-Mossel preenrichment medium and incubated at 35∘C
for 20 hours. One milliliter aliquots of preenriched cultures
was mixed with nine milliliters of 2x EC medium and
incubated at 35∘C for 20 hours. One loop full of the culture
was inoculated into 10milliliters 1x ECmediumwithDurham
fermentation tubes and incubated at 42∘C for 20 hours. To
isolate E. coli, one loop full of gas produced 1x EC culture
broth was streaked on Chromocult agar (CTA) plates and
developed typical colonies. The same preenrichment culture
was used for isolation and characterization of coliform
bacteria on Sorbitol MacConkey (SMAC) agar.
2.7. Salmonella spp. Twenty-five (25) g of each sample was
homogenized in 225mL of buffered peptone water and
incubated at 35∘C for 20 hours. One milliliter preenrichment
culture wasmixedwith ninemilliliters ofHanja Tetrathionate
Broth and incubated at 35∘C for 20 hours and nine milliliters
of Rappaport-Vassiliadis Broth and incubated at 42∘C for
20 hours. The culture broths were subsequently streaked
onto Bismuth Sulfite Agar (BSA). For the isolation of each
microorganism, original solution and 10−2 (hundred times
diluted solution) were used for microbial limit test and pH
of the samples was controlled within the range of 6.9–7.9 by
adding NaOH or HCL.
2.8. Qualitative Fungi Counts. Fungi were identified on
potato dextrose agar (PDA) (Oxoid Ltd., Hampshire, Eng-
land) after incubation at 30∘C for 5 days. Procedure and
dilution were followed as described for total bacterial aerobic
count. At the end of 5-day incubation, the fungal growth was
observed under microscope [20].
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ADHP-1 2.0 × 104 2.0 × 102 Negative Negative Negative
ADHP-2 1.4 × 106 Negative Negative Negative Negative
ADHP-3 4.0 × 104 2.7 × 10
3,
1.7 × 103 (w, c) Negative Negative Negative
ADHP-4 5.72 × 106 8.4 × 10
3 (P)
8.00 × 102 (W)
3.1 × 103 (W)
6.0 × 102 (P) Negative 2.75 × 10
3
ADHP-5 2.9 × 105 Negative Negative Negative Negative
ADHP-6 5.7 × 105 Negative Negative Negative Negative
ADHP-7 7.08 × 104 2.08 × 104 2.34 × 104 Negative Negative
ADHP-8 5.36 × 104 Negative Negative Negative Negative
ADHP-9 2.5 × 105 2.89 × 103 9.5 × 102 4.4 × 102 Negative
ADHP-10 8.3 × 105 8.0 × 102 2.9 × 102 Negative Negative
ADHP-11 1.38 × 106 3.93 × 104 1.34 × 10
4 (P)
7.8 × 103 (W) 2.1 × 10
3 (P) Negative
ADHP-12 2.03 × 104 Negative Negative Negative Negative
ADHP-13 1.87 × 106 5.0 × 103 5.0 × 10
2 (P)
1.6 × 103 (W) 1 × 10
2 (P) Negative
2.9. Sample Preparation and Heavy Metal Analysis. Heavy
metals were analyzed in flame atomizer based atomic absorp-
tion spectrometer using hollow cathode lamp as a radiation
source. Accurately, 25 g of herbal preparation was transferred
into silica crucible and kept in a muffle furnace for ashing
at 700∘C for 1 hour. The sample was then cooled down
to room temperature and the heating process was repeated
for three times. The ash was then dissolved by adding 5–
10mL of concentrated HCl and finally diluted the sample by
0.1 NHNO
3
up to 25mL. Finally, the sample was prepared
for heavy metal analysis by filtering through Whatman filter
paper.
For heavy metal analysis, the samples were aspirated
throughnebulizer and the absorbancewasmeasured against a
blank as a reference. Specific hollow cathode lamps were used
to analyze Copper (wavelength 324.8 nm), Cadmium (wave-
length 228.8 nm), Chromium (wavelength 357.9 nm), Man-
ganese (wavelength 297.5 nm), Lead (wavelength 283.3 nm),
and Zinc (wavelength 213.9 nm). Before analysis, the samples
were diluted to the appropriate factor according to the
detection limit of the Atomic Absorption Spectrophotometer
(AAnalyst 200; Perkin Elmer, USA). Calibration curve was
obtained using referent standard and all the measurements
were run in triplicate for the samples and standards solutions.
3. Results and Discussion
3.1.Microbial Contamination. For the evaluation ofmicrobial
contamination, total bacterial aerobic, total coliform, total E.
coli, E. coli 0157, and Salmonella spp. count were determined
(Figure 1). All the preparations showed different levels of
total aerobic bacterial count and exceeded the safety limit
according to USP (United States Pharmacopoeia) (Tables 2
and 3), but six of them (ADHP-2, ADHP-4, ADHP-6, ADHP-
10, andADHP-11) exceeded the safety limit as indicated by EP
(European Pharmacopoeia) and WHO (World Health Orga-
nization) guidelines (Table 3) whereas two of them (ADHP-5
and ADHP-9) were in marginal level. Total coliform count
is the indicator of faecal contamination and is found in six
of the samples where they exceeded the safety limit (Tables 2
and 3). Total E. coli count, a specific Gram negative bacterial
species count included in the range of total coliform count,
also exceeded the safety limit in fifty percent of the studied
preparation. Specific species counts such as E. coli 0157 and
Salmonella spp. were found to be present in around 25%
of the preparation (E. coli 0157 in ADHP-9, ADHP-11, and
ADHP-13 and Salmonella spp. in ADHP-4) (Tables 2 and 3).
Almost seventy percent of the total preparation studied (nine
preparations) failed to comply with the safety limit at least in
one method of microbial contamination evaluation like total
microbial counts or specific species count. In this study, we
counted microorganism in five different ways (total aerobic
bacterial count, total coliform count, total E. coli count,
specific E. coli 0157 count, and Salmonella spp. count), where
ADHP-4 and ADHP-11 exceeded safety limit in four different
microbial counting methods. ADHP-9 is in second position
in failing the safety limit as it exceeded the safety limit
evaluated by three different counts. At least in two different
microbial counts, the level of microbial contamination was
higher than the safety limit in ADHP-7, ADHP-10, and
ADHP-13 as mentioned in the EP, USP, andWHO guidelines
(Tables 2 and 3). From the data, it is found that two of these
preparations (ADHP-1 and ADHP-12) only could be able to
comply with the safety limit evaluated by all the different
microbial counts. If we consider the presence of fungi in
the preparation then none of these herbal preparations could
comply with different standardizing body for the assurance
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Table 3: Microbial limits for finished herbal/botanical preparations (in colony-forming units/gram (cfu/g) or colony-forming units/mL
(cfu/mL)) (current as of July 2014).
Reference EP category C USP WHO
Product
Product with Ingredients






Total aerobic microbial count 10
5 (maximum acceptance limit:
5 × 105) 10
4 105
Total combined yeast and mold
count
104 (maximum acceptance limit:





104 NA 103 (other than E. coli)
Escherichia coli Absence in 1 g Absence in 10 g 10 in 1 g
Salmonella spp. Absence in 25 g Absence in 10 g Absence in 1 g
Staphylococcus aureus NA NA NA
Clostridia NA NA Absence in 1 g
Shigella NA NA Absence in 1 g
EP: European Pharmacopoeia Edition 8.0, 5.1.8 (microbiological quality of herbal medicinal products for oral use and extracts used in their preparation), 2013.
USP: United States Pharmacopeial Convention, USP-NF 37-32, 2014.




ADHP-7 in Chromocult agar
(b)
ADHP-7 in SMAC agar
(c)
ADHP-11 in SMAC agar
(d)




Figure 1: Incubation of antidiabetic herbal preparations (ADHPs) in different agar media for microbial count. (a) ADHP-9 incubated in
Tryptic Soya Agar (TSA) plate for total aerobic count, (b) ADHP-7 incubated in Chromocult agar plate for total coliform count, (c) ADHP-7
and ADHP-11 incubated in Sorbitol MacConkey (SMAC) agar plate for total E. coli count, (e) ADHP-6 incubated in caprylate-thallous Agar
(CTA) plate for E. coli 0157 count, and (f) ADHP-11 incubated in Bismuth Sulfite Agar (BSA) plate for Salmonella spp. count.
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Table 4: Heavy metal content of investigated ADHP samples.
Sample ID Zn (ppm) Cu (ppm) Mn (ppm) Cr (ppm) Cd (ppm) Pb (ppm)
ADHP-1 5.38 5.38 6.5 9.25 BDL 8.50¶
ADHP-2 3.75 10.00 9.25 4.63 BDL 8.50¶
ADHP-3 2.00 10.50 6.63 4.38 BDL 7.00¶
ADHP-4 12.50 3.50 7.75 28.25 2.75∗§¶ 41.38∗
ADHP-5 2.88 4.88 1.63 8.25 BDL 6.63¶
ADHP-6 3.75 4.50 8.50 4.00 BDL 13.38∗¶
ADHP-7 BDL 4.13 3.00 2.88 BDL 3.75
ADHP-8 2.75 3.75 0.88 6.00 BDL 11.50∗¶
ADHP-9 2.88 8.88 6.88 BDL BDL 3.88
ADHP-10 2 7.25 8.50 11.75 BDL 9.88¶
ADHP-11 2.38 4.50 8.00 2.13 BDL 5.75¶
ADHP-12 BDL 4.25 4.63 2.50 BDL 9.38¶
ADHP-13 10.50 3.13 6.00 24.63 1.38∗§¶ 33.50∗§¶
BDL: belowdetection level; ∗exceedWHOandUSFDApermission limit; §exceedHAS Singapore permission limit; ¶ exceedChines Pharmacopoeia permission
limit.
of safety as all of the thirteen ADHPs have shown positive
response in potato dextrose agar (PDA) (Figure 2).
The presence of large numbers of pathogenic bacteria in
the studied herbal preparations indicates several windows to
consider as a source of contamination. It is worthmentioning
that the pH of all the preparations was within the suitable
range (pH 5–8.5) which may appreciate bacterial growth
[21]. The contamination could start at the initial phase of
raw materials collection as soil influences bacterial growth
in several ways. This initial contamination could be carried
along to harvesting, drying, and storage. Moreover, during
the preparation of finished preparation, the source of con-
tamination includes personnel, equipments, and materials.
Therefore, the process of raw material collections and pro-
cessing of the rawmaterials and the process ofmanufacturing
for finished preparation should ensure the highest possible
level of hygiene to maintain the lowest possible level of
pathogenic organism in the preparation and thereby assure
the quality and safety of herbal preparation.
The level of microbial contamination is mentioned in
different standards for publication including EP, USP, and
WHO guideline to maintain the safety of herbal preparations
(Table 3). Gramnegative bacteria such as Salmonella, Shigella,
and E. coli should be absent in the preparation. Moreover,
the limit for coliforms is also mentioned, as it is the most
reliable indicator of faecal contamination,whichmay indicate
the possible presence of other harmful disease-causing organ-
isms. The presence of fungi in herbal preparations under
certain conditions may lead to the secretion of toxic metabo-
lites such as mycotoxins, which when ingested, inhaled,
or absorbed through the skin cause illness or human and
animal death [22]. These mycotoxins possess substantial risk
of carcinogenic, neurotoxic, immunotoxic, and mutagenic
effects [11–16]. It is reported that a substantial amount of
medicinal plants is contaminated naturally by fungi from soil
and environment and thereby may contain mycotoxins [10].
Asmost of the herbal preparationmajorly containsmedicinal
plants, it is important to assure that the levels of mycotoxins
ADHP-8 in PDA
Figure 2: Incubation of ADHP-8 in potato dextrose agar (PDA).
are below the safety limit as set by different bodies. For
conclusive remark, we further need to determine the level of
mycotoxins in these herbal preparations.
3.2. HeavyMetal Content. In this study, we determined heavy
metal (Cu, Cd, Cr, Mn, Pb, and Zn) contents in different
ADHPs to identify any potential risk of the accumulation
of these heavy metals leading to toxicity (Table 4). All the
thirteen ADHPs contain Copper (Cu), Chromium (Cr),
Manganese (Mn), Lead (Pb), and Zinc (Zn) in some levels
with few exceptions (Cr in ADHP-9 and Zn in ADHP-7
and ADHP-12 were below detection level) (Table 4). The
amount of cadmium was below detection level in all the
preparations except ADHP-4 andADHP-13.There are several
regulatory bodies that set specific allowable limit for heavy
metal content in herbal and tradition preparations based on
different guidelines and this permissible limit varies among
these regulatory bodies (Tables 5 and 7). It is found that lead
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Table 5: Permissible limit of heavy metal in herbal drugs.
Heavy/toxic metal WHO US FDA HSA Singapore Chinese Pharmacopoeia
Cadmium 0.20 ppm 0.30 ppm 0.05 ppm 0.30 ppm
Lead 10.00 ppm 10.00 ppm 20.00 ppm 5.00 ppm
Arsenic 10.00 ppm 10.00 ppm 5.00 ppm 2.00 ppm
Mercury 1.00 ppm 1.0 ppm 0.50 ppm 0.20 ppm
Copper 20.00 ppm 20.00 ppm 150.00 ppm 20.00 ppm
Zinc 50.00 ppm 50.00 ppm — —
US FDA: United States Food and Drug Administration; HAS: Health Science Authority.
Table 6: Heavy metal content of investigated ADHP samples and the daily safe intake of different heavy metals.
Sample ID Cumulative daily adult doseof preparation∗ (g)
Daily adult intake of heavy metal (in 𝜇g) as calculated form
the dose indicated on the label of the finished product
Zn Cu Mn Cr Cd Pb
ADHP-1 1.50 8.06 8.06 9.75 13.88 — 12.75
ADHP-2 1.00 3.75 10.00 9.25 4.63 — 8.50
ADHP-3 3.00 6.00 31.50 19.88 13.13 — 21.00
ADHP-4 2.50 31.25 8.75 19.38 70.63 6.88 103.44
ADHP-5 2.50 7.19 12.19 4.06 20.63 — 16.56
ADHP-6 3.75 14.06 16.88 31.88 15.00 — 50.16
ADHP-7 4.00 — 16.50 12.00 11.00 — 15.00
ADHP-8 3.50 9.63 13.13 3.06 21.00 — 40.25
ADHP-9 30.00 86.25 266.25 206.25 — — 116.25
ADHP-10 2.50 5.00 18.13 21.25 29.38 — 24.69
ADHP-11 2.50 5.94 11.25 20.00 5.31 — 14.38
ADHP-12 4.00 — 17.00 18.50 10.00 — 37.50
ADHP-13 2.50 26.25 7.81 15.00 61.56 3.44 83.75
∗This dose is calculated as indicated on the label of the finished product; BDL: below detection level.
content in almost all of the samples (except ADHP-7 and
ADHP-9) exceeded the permissible limit if we consider the
stringiest limit of Chines Pharmacopoeia (Tables 4 and 5).
Even if we consider a more relax permissible limit for lead
(WHO and US FDA guidelines; Table 5), one-third of the
total ADHPs (ADHP-4, ADHP-6, ADHP-8, and ADHP-13)
failed to comply with the safety limit. Lead, a highly toxic
environmental pollutant, can affect the function of various
biomolecules by forming complex with them. Moreover,
excess lead exposure may be responsible for poor muscle
coordination, gastrointestinal symptoms, brain and kidneys
damage, hearing and vision impairments, and reproductive
defects [23–25]. Cadmium content was below detection
level in all of the ADHP samples other than ADHP-4 and
ADHP-13. Unfortunately, these two (ADHP-4 and ADHP-13)
samples also failed to comply with safety based on cadmium
content (Tables 4 and 5). Cadmium toxicity could induces
tissue injury [26–28], epigenetic changes in DNA expression
[29–31], hypertension [32], diabetes [33], apoptosis [34], and
insulin resistance [35, 36]. Moreover, excess cadmium may
inhibit or upregulate transport pathways [37–39] and heme
synthesis [40]. According to JECFA (The Joint FAO/WHO
Expert Committee on Food Additives) heavy metal limits
for herbal dietary supplements, none of these formulations
Table 7: JECFA heavy metal limits for herbal dietary supplements.
Heavy metals Stated limit(PTWI, weekly)
Calculated daily
limit (adult, 70 kg)
Arsenic 15 𝜇g inorganic arsenic/kg bw 150 𝜇g
Cadmium 7 𝜇g cadmium/kg bw 70 𝜇g
Lead 25𝜇g lead/kg bw 250 𝜇g
Mercury 1.6 𝜇g methylmercury/kg bw 16 𝜇g
JECFA: The Joint FAO/WHO Expert Committee on Food Additives; PTWI:
provisional tolerable weekly intake.
contains heavy metals in such a level, which could exceed
the daily allowable intake (Tables 6 and 7). Considering
all of these guidelines, it turned out that only two ADHP
samples (ADHP-7 and ADHP-9) contain heavy metals in
safe level. Metals are natural components of soils and some
of them (Cu, Mn, and Zn) are necessary for micronutrients
of plant growth while others (Cd, Cr, and Pb) are not but
could be accumulated in plants at toxic level [41–43]. As the
major components of these herbal preparations are plants, the
presence of heavy metals in ADHPs is very relevant. Some of
the identified metals (Zn, Cu, Mn, and Cr) have important
biological role in the body.
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4. Conclusion
Based on at least two of the evaluation experiments, all of
the ADHPs were found to be contaminated with microor-
ganism and/or fungi, which pose potential threat to human
health. The heavy metal content particularly Lead in ADHP
samples was alarming as almost all of them failed to
comply with safety limit. Further detection of other heavy
metal content like arsenic and mercury could give us a
broader understanding of heavy metal contamination in
these herbal preparations. In general, this contamination
may come from raw materials, during processing of raw
materials and manufacturing of finished products due to
the production environment. In a nutshell, finished products
reach consumers with zero contamination; quality has to
be maintained throughout the process beginning from the
selection of raw material to the final product. Taking these
facts into consideration, regulatory agencies should come
forward and take the necessary measures to ensure the safety
of finished herbal preparations.
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